
Stryker
LEI 5493002F0SC4JTBU5137, SWIFT STYCUS33XXX
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡
- 債券検索
- ウォッチリスト
- Excelアドイン
取引スケジュール 発行体マップ
クオート
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
プロフィール
|
Stryker Corporation (Stryker) is a medical technology company. Stryker offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. The Company operates in three business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Its products include implants used in joint replacement, trauma, and spinal surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, as well as other medical device products used in a variety of medical specialties. In June 2011 the Company acquired Orthovita, Inc. (Orthovita). In July 2011, it acquired Memometal Technologies (Memometal). In October 2011, it acquired Concentric Medical, Inc. (Concentric). In February 2011, it sold its OP-1 product family. In January 2011, it acquired assets of the Neurovascular division of Boston Scientific Corporation (Neurovascular).
|
基本情報
-
組織名Stryker Corporation
-
組織ステータスOperating organization
-
住所2825 Airview Boulevard Kalamazoo, USA, 49002
-
サイト
-
IRサイト
IFRS/US GAAP報告書
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |